ClinicalTrials.govpublic full text
Effects of Docosahexanoic Acid on Neurocognitive Impairment in HIV-infected Patients
neurocognitive impairment, hiv-infected patients, gut microbiota, fatty acid docosahexaenoic, randomized controlled trial, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 878591
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.